APA (7th ed.) Citation

Hureau, M., Gaudet, A., Caires, N. D. F., Parmentier, E., Poissy, J., Duburcq, T., . . . Mathieu, D. (2019). Endocan is a reliable biomarker during continuous renal replacement therapy. Critical Care, 23(1), 1. https://doi.org/10.1186/s13054-019-2585-4

Chicago Style (17th ed.) Citation

Hureau, Maxence, Alexandre Gaudet, Nathalie De Freitas Caires, Erika Parmentier, Julien Poissy, Thibault Duburcq, Philippe Lassalle, and Daniel Mathieu. "Endocan Is a Reliable Biomarker During Continuous Renal Replacement Therapy." Critical Care 23, no. 1 (2019): 1. https://doi.org/10.1186/s13054-019-2585-4.

MLA (9th ed.) Citation

Hureau, Maxence, et al. "Endocan Is a Reliable Biomarker During Continuous Renal Replacement Therapy." Critical Care, vol. 23, no. 1, 2019, p. 1, https://doi.org/10.1186/s13054-019-2585-4.